LFST - Masking returns to some U.S. hospitals amid rising COVID flu cases
2024-01-04 13:51:02 ET
More on BioNTech, Moderna, etc.
- Pfizer: If You Missed The Pandemic Entry, Here's Another Chance
- BioNTech's Strategic Shift: Diversifying Into Cancer Therapeutics
- The Pfizer Advantage: High Dividend Yield, JN.1 Variant, And Therapeutic Innovations
- Pfizer wins Canada approval for hemophilia B gene therapy
- 4 stocks to watch on Wednesday: Apple, Moderna and more
For further details see:
Masking returns to some U.S. hospitals amid rising COVID, flu cases